|
|
Reprogen Financing
*
* Prior Firm Experience
Solicited, negotiated and closed $6.5 million private financing increasing market capitalization from $5 million to more than $16 million; investors included Oxford Bioventures, Hambrecht & Quist, UBS, GeneChem, Global Life Sciences and GIMV.
|
 |
|